Landscape of Targeted Anti-Cancer Drug Synergies in Melanoma Identifies a Novel BRAF-VEGFR/PDGFR Combination Treatment

• Adam A. Friedman ,

  * E-mail: aafriedman@partners.org (AAF); cbenes@partners.org (CHB); dfisher3@partners.org (DEF)

  Affiliations Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, United States of America, Dermatology and Cutaneous Biology Research Center, Massachusetts General Hospital, Charlestown, Massachusetts, United States of America

  ⨯
• Arnaud Amzallag,

  Affiliation Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Iulian Pruteanu-Malinici,

  Affiliation Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Subash Baniya,

  Affiliations Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, United States of America, Dermatology and Cutaneous Biology Research Center, Massachusetts General Hospital, Charlestown, Massachusetts, United States of America

  ⨯
• Zachary A. Cooper,

  Affiliations Department of Surgical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States of America, Department of Genomic Medicine, University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Adriano Piris,

  Affiliation Division of Dermatopathology, Massachusetts General Hospital, Boston, Massachusetts, United States of America

  ⨯
• Leeza Hargreaves,

  Affiliations Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, United States of America, Dermatology and Cutaneous Biology Research Center, Massachusetts General Hospital, Charlestown, Massachusetts, United States of America

  ⨯
• Vivien Igras,

  Affiliations Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, United States of America, Dermatology and Cutaneous Biology Research Center, Massachusetts General Hospital, Charlestown, Massachusetts, United States of America

  ⨯
• Dennie T. Frederick,

  Affiliation Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Donald P. Lawrence,

  Affiliation Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Daniel A. Haber,

  Affiliations Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, United States of America, Howard Hughes Medical Institute, Chevy Chase, Maryland, United States of America

  ⨯
• Keith T. Flaherty,

  Affiliation Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Jennifer A. Wargo,

  Affiliations Department of Surgical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States of America, Department of Genomic Medicine, University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Sridhar Ramaswamy,

  Affiliation Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Cyril H. Benes ,

  * E-mail: aafriedman@partners.org (AAF); cbenes@partners.org (CHB); dfisher3@partners.org (DEF)

  Affiliation Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
•  [ ... ],
• David E. Fisher

  * E-mail: aafriedman@partners.org (AAF); cbenes@partners.org (CHB); dfisher3@partners.org (DEF)

  Affiliations Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, United States of America, Dermatology and Cutaneous Biology Research Center, Massachusetts General Hospital, Charlestown, Massachusetts, United States of America

  ⨯
• [ view all ]
• [ view less ]